Search Results - "Schiller, Crystal E."
-
1
Perimenopausal Effects of Estradiol on Anhedonia and Psychosis Study (PEEPs): study protocol for a neural and molecular mechanistic clinical trial
Published in Current controlled trials in cardiovascular medicine (28-02-2023)“…The perimenopausal transition is accompanied by psychiatric symptoms in over 10% of women. Symptoms commonly include depressed mood and anhedonia and less…”
Get full text
Journal Article -
2
Psychological distress and treatment preferences among parents amidst the COVID-19 pandemic
Published in Psychiatry Research Communications (01-06-2023)“…The COVID-19 pandemic has presented many stressors for parents. This study was conducted to examine treatment preferences and barriers to care amidst COVID-19…”
Get full text
Journal Article -
3
ACT for Lupus: Pilot Feasibility and Acceptability Study of a Novel Web‐Based Acceptance and Commitment Therapy Program for Patients With Lupus
Published in ACR open rheumatology (01-07-2022)“…Objective Acceptance and commitment therapy (ACT) has demonstrated effectiveness in addressing symptoms of anxiety and depression, frequently experienced by…”
Get full text
Journal Article -
4
Temporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition
Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2024)“…The hormonal changes of pregnancy and parturition can trigger robust changes in affective state, particularly among patients with a history of postpartum…”
Get full text
Journal Article -
5
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2016)“…Changes in neurosteroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms. To test this hypothesis, we stabilized…”
Get full text
Journal Article -
6
The development and evaluation of a brief intervention for male partners of women hospitalized for perinatal distress
Published in Journal of affective disorders (01-02-2021)“…•Feasibility rates may be particularly high for treatment engagement of male partners of women experiencing PD, despite the reluctance that many men otherwise…”
Get full text
Journal Article -
7
Culturally Sensitive Psychotherapy for Perinatal Women: A Mixed Methods Study
Published in Journal of consulting and clinical psychology (01-10-2022)“…Objective: There is a critical need to better understand psychological treatments from a culturally sensitive lens. Using a process-oriented model, we examined…”
Get full text
Journal Article -
8
Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study
Published in Psychopharmacology (01-04-2016)“…Rationale Anxiety during pregnancy has been linked to adverse maternal health outcomes, including postpartum depression (PPD). However, there has been limited…”
Get full text
Journal Article -
9
Adapting behavioral activation for perinatal depression and anxiety in response to the COVID-19 pandemic and racial injustice
Published in Journal of affective disorders (15-02-2022)“…•BA offers a person-centered model to facilitate social connection through creative problem-solving for women with perinatal depressive and anxiety symptoms…”
Get full text
Journal Article -
10
A Theoretical Framework for Treating Perinatal Depression Using Couple-Based Interventions
Published in Psychotherapy (Chicago, Ill.) (01-12-2017)“…Between 10% and 20% of women will experience depression in the perinatal period, which begins during pregnancy and extends into the first year after delivery…”
Get full text
Journal Article -
11
Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder
Published in Psychoneuroendocrinology (01-05-2016)“…Highlights • We examine associations between abuse and hormone sensitivity in MRMD. • Main effects of person-centered estradiol and progesterone were small to…”
Get full text
Journal Article -
12
Acceptability of a Randomized Trial of Anti-depressant Medication or Interpersonal Therapy for Treatment of Perinatal Depression in Women with HIV
Published in AIDS and behavior (01-04-2024)“…Postpartum depression (PPD) affects nearly 20% of postpartum women in Sub-Saharan Africa (SSA), where HIV prevalence is high. Depression is associated with…”
Get full text
Journal Article -
13
Scaling up quality-assured psychotherapy: The role of therapist competence on perinatal depression and anxiety outcomes
Published in General hospital psychiatry (01-07-2023)“…To examine: (1) the psychometric properties of two therapist competence measures—multiple choice questionnaire (MCQ) and standardized role-plays; (2) whether…”
Get full text
Journal Article -
14
Ovarian hormones influence eating disorder symptom variability during the menopause transition: A pilot study
Published in Eating behaviors : an international journal (01-12-2019)“…•Female reproductive hormones influence changes in eating disorder symptoms.•The menopause transition is a time of chaotic reproductive hormone change for…”
Get full text
Journal Article -
15
Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial
Published in Journal of the International AIDS Society (01-07-2022)“…Introduction Postpartum depression (PPD) is a prevalent and debilitating disease that may affect medication adherence and thus maternal health and vertical…”
Get full text
Journal Article -
16
-
17
5 alpha -Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2016)“…Changes in neurosteroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms. To test this hypothesis, we stabilized…”
Get full text
Journal Article -
18
5[alpha]-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2016)“…Changes in neurosteroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms. To test this hypothesis, we stabilized…”
Get full text
Journal Article